Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis
- PMID: 21397948
- DOI: 10.1016/j.ophtha.2010.12.032
Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis
Abstract
Purpose: To evaluate retention of visual acuity and development of complications after Boston type 1 keratoprosthesis implantation over a longer follow-up period than previously reported.
Design: Cohort study.
Participants: Forty eyes of 35 patients who underwent Boston type 1 keratoprosthesis surgery at the University of California, Davis, between 2004 and 2010.
Methods: Preoperative, intraoperative, and postoperative parameters were collected and analyzed.
Main outcome measures: Best-corrected visual acuity (BCVA) and postoperative complications.
Results: Preoperative visual acuity ranged from 20/150 to light perception and was ≤20/400 in 38 eyes (95%). Preoperative diagnoses included failed corneal transplants (19 eyes, 47.5%), chemical injury (10 eyes, 25%), and aniridia (5 eyes, 12.5%). Mean follow-up duration was 33.6 months (range, 5-72 months). Of 36 eyes followed for ≥1 year, 32 eyes (89%) achieved postoperative BCVA ≥20/200. Of eyes that achieved BCVA ≥20/200, at last follow-up, 19 of 32 eyes (59%) followed for ≥1 year retained BCVA ≥20/200; 16 of 27 eyes (59%) followed for ≥2 years retained BCVA ≥20/200; 7 of 14 eyes (50%) followed for ≥3 years retained BCVA ≥20/200; and 2 of 7 eyes (29%) followed for ≥4 years retained BCVA ≥20/200. End-stage glaucoma most commonly caused vision loss (7 of 13 eyes, 54%) when BCVA ≥20/200 was not retained (follow-up ≥1 year). Glaucoma was newly diagnosed in 11 eyes (27.5%); progression was noted in 9 eyes (22.5%). Glaucoma drainage device erosion occurred in 9 eyes (22.5%). Retroprosthetic membrane formed in 22 eyes (55%), 5 eyes (12.5%) developed endophthalmitis, 6 eyes (15%) developed corneal melt, 7 eyes (17.5%) underwent keratoprosthesis replacement, and 23 eyes (57.5%) required major surgery to treat postoperative complications. The initial keratoprosthesis was retained in 32 eyes (80%).
Conclusions: Keratoprosthesis implantation remains a viable option for salvaging vision. A significant number of patients lost vision over the postoperative course. Glaucoma and complications related to glaucoma surgery are significant challenges to maintaining good vision after keratoprosthesis surgery. Our study highlights the need for long-term follow-up and a team approach to management, and points to a more guarded long-term visual prognosis after surgery.
Financial disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Comment in
-
Keratoprosthesis surveillance cultures.Ophthalmology. 2012 Jan;119(1):202-3; author reply 203. doi: 10.1016/j.ophtha.2011.09.034. Ophthalmology. 2012. PMID: 22214949 No abstract available.
Similar articles
-
Boston type 1 keratoprosthesis: the university of california davis experience.Cornea. 2009 Apr;28(3):321-7. doi: 10.1097/ICO.0b013e31818b8bfa. Cornea. 2009. PMID: 19387235
-
The Boston type I keratoprosthesis: improving outcomes and expanding indications.Ophthalmology. 2009 Apr;116(4):640-51. doi: 10.1016/j.ophtha.2008.12.058. Epub 2009 Feb 25. Ophthalmology. 2009. PMID: 19243830
-
Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis.Am J Ophthalmol. 2011 Aug;152(2):209-18. doi: 10.1016/j.ajo.2011.01.034. Epub 2011 Jun 2. Am J Ophthalmol. 2011. PMID: 21636070
-
Boston keratoprosthesis type 1 for limbal stem cell deficiency after severe chemical corneal injury: A systematic review.Ocul Surf. 2018 Jul;16(3):272-281. doi: 10.1016/j.jtos.2018.03.007. Epub 2018 Mar 26. Ocul Surf. 2018. PMID: 29597010
-
[Treatment of vascularized high-risk eyes with a Boston keratoprosthesis].Ophthalmologe. 2021 Jun;118(6):544-552. doi: 10.1007/s00347-021-01356-x. Epub 2021 Mar 17. Ophthalmologe. 2021. PMID: 33730307 Review. German.
Cited by
-
Keratoprosthesis prophylaxis: is it time for a paradigm shift?Clin Ophthalmol. 2018 Sep 12;12:1785-1788. doi: 10.2147/OPTH.S178622. eCollection 2018. Clin Ophthalmol. 2018. PMID: 30254417 Free PMC article.
-
Artificial corneas versus donor corneas for repeat corneal transplants.Cochrane Database Syst Rev. 2014 Nov 5;11(11):CD009561. doi: 10.1002/14651858.CD009561.pub2. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2020 May 13;5:CD009561. doi: 10.1002/14651858.CD009561.pub3. PMID: 25372407 Free PMC article. Updated.
-
Streptococcus agalactiae Endophthalmitis in Boston Keratoprosthesis in a Patient with Steven-Johnson Syndrome.Middle East Afr J Ophthalmol. 2016 Oct-Dec;23(4):329-331. doi: 10.4103/0974-9233.194095. Middle East Afr J Ophthalmol. 2016. PMID: 27994401 Free PMC article.
-
Corneal graft dellen in a patient implanted with a Boston keratoprosthesis type 1.Int Ophthalmol. 2017 Feb;37(1):263-266. doi: 10.1007/s10792-016-0227-2. Epub 2016 Apr 11. Int Ophthalmol. 2017. PMID: 27068827
-
High-resolution spectral domain anterior segment optical coherence tomography in type 1 Boston keratoprosthesis.Cornea. 2013 Jul;32(7):951-5. doi: 10.1097/ICO.0b013e318285c8f4. Cornea. 2013. PMID: 23591146 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical